The Hidden Role of Oxygen in Cancer (CFCs), Metabolism, and Chronic Conditions
Share on:

Oxygen is so familiar that we rarely question it. Yet this invisible molecule has shaped Earth's atmosphere, driven the evolution of complex life, and continues to regulate human biology at every level. This blog explores how oxygen governs life in nature and within our cells – and why disruptions in oxygen balance are a shared feature of chronic illness and cancer.
Oxygen: The Invisible Architect of Life on Earth
Planet Earth: Oxygen as the foundation of complex life
Most organisms use oxygen (O₂) to produce energy through aerobic respiration, a process that yields far more ATP than anaerobic pathways and makes large, active, and complex life forms possible. Sustained oxygen availability is therefore essential for multicellular organisms and complex ecosystems to exist and thrive.
Oxygen is central to Earth's physical systems. Produced by photosynthesis, it now makes up about 21% of the atmosphere and supports aerobic life. In the upper atmosphere, oxygen forms ozone, which shields the planet from ultraviolet radiation and allows life to thrive on land.
But it wasn't always like that…
For much of Earth's early history, free oxygen was nearly absent. The evolution of oxygenic photosynthesis triggered the Great Oxidation Event around 2.4 billion years ago, fundamentally transforming Earth's chemistry and biology. Later rises in oxygen levels coincided with the emergence of complex multicellular life, suggesting that oxygen availability helped set the pace of evolution.
Across Earth's history, oxygen has never been static. Fluctuating oxygen levels acted as a constraint – determining where life could exist, how large organisms could grow, and how complex biological systems could become.

From Planetary Oxygen to Human Physiology
The same oxygen that reshaped Earth's atmosphere is now central to human biology. Just as planetary oxygen levels once limited the evolution of life, oxygen availability within the human body governs cellular energy production, gene regulation, immune function, and tissue repair. Oxygen is not only a metabolic fuel – it is also a biological signal that directs cells to grow, adapt, conserve energy, or initiate repair.
Oxygen in the Human Body: Transport, Sensing, and Balance
In humans, oxygen serves as the final electron acceptor in cellular respiration, enabling efficient ATP (adenosine triphosphate) production within mitochondria. To support this process, the body has evolved tightly regulated systems that deliver oxygen from the atmosphere to every cell. Oxygen enters through the lungs, binds to hemoglobin in red blood cells, and is delivered to tissues where it fuels mitochondrial ATP production.
Oxygen delivery is continuously monitored and adjusted. At the molecular level, cells sense oxygen using oxygen-dependent enzymes that regulate hypoxia-inducible factors (HIFs). Under normal oxygen conditions, HIFs are degraded; when oxygen levels fall, HIFs stabilize and activate genes that support survival under low-oxygen conditions. At the organ and whole-body level, oxygen availability influences breathing rate, heart output, blood flow distribution, and red blood cell production (erythropoiesis).
These coordinated responses maintain oxygen homeostasis and allow the body to adapt to both oxygen shortage and excess. When oxygen delivery or utilization is impaired, cellular dysfunction, tissue damage, and illness can result.
Oxygen as a Regulator of Energy, Genes, and Signaling
Oxygen regulates life at multiple biological levels. First, it acts as the body's energy "throttle." When oxygen is plentiful, mitochondria efficiently generate ATP to support growth, repair, and normal physiological function. When oxygen levels fall – a state known as hypoxia – cells rapidly shift priorities. Energy-intensive processes are suppressed, metabolism shifts toward less efficient pathways such as glycolysis, and mitochondrial activity is reprogrammed to favor survival over growth.
Beyond energy metabolism, oxygen directly regulates gene expression and cell signaling. Oxygen-sensitive enzymes control HIF activity, turning on genes involved in angiogenesis, glucose metabolism, erythropoiesis, and cell survival during low-oxygen states. Oxygen levels influence various biological processes by affecting enzymes that modify chromatin structure, DNA and RNA methylation, and protein stability, which in turn can reshape gene expression throughout the genome.
Oxygen also gives rise to reactive oxygen species (ROS), which act as essential signaling molecules in pathways governing immunity, stress responses, cell proliferation, and programmed cell death. While excessive ROS can cause cellular damage, insufficient ROS disrupts normal signaling – highlighting the importance of balance rather than elimination.
These oxygen-sensing and response mechanisms are deeply conserved across evolution and remain central to human physiology today.

Hypoxia and Chronic Disease: A Shared Biological Environment
Forms of Hypoxia: Why Context Matters
Hypoxia refers to reduced oxygen availability, but its biological effects depend on how quickly it develops, how long it lasts, and whether adaptation is possible.
High-altitude hypoxia
Caused by reduced oxygen pressure. Acute exposure may lead to acute mountain sickness (AMS), pulmonary or cerebral edema. Chronic exposure can result in chronic mountain sickness, characterized by excessive red blood cell production and impaired oxygen delivery despite adaptation. Acclimatization includes increased ventilation, erythropoiesis, and vascular changes, which can become pathological if exaggerated.
Acute hypoxia from injury
Results from sudden disruption of blood flow or oxygen supply (e.g., trauma, ischemia). Triggers rapid cellular stress, inflammation, mitochondrial dysfunction, and tissue damage. Mediated by HIF-1α activation and mitophagy; iron availability influences injury severity and recovery.
Chronic hypoxia in disease
Occurs in long-term high-altitude residence and many chronic illnesses. Leads to sustained adaptations including angiogenesis, metabolic reprogramming, and altered immune signaling. Can support survival initially, but prolonged hypoxia contributes to maladaptive remodeling, pulmonary hypertension, heart failure, and tissue degeneration.
Hypoxia is not a single condition. Its biological impact depends on onset, duration, and the capacity for adaptation – distinctions that are critical when considering chronic disease and therapeutic oxygen strategies.
Chronic Inflammation and Tissue Hypoxia
Chronic tissue hypoxia and inflammation are closely linked in many chronic illnesses, where hypoxia arises from increased oxygen demand by metabolically active immune and resident cells combined with impaired oxygen supply due to vascular dysfunction. This hypoxic environment activates hypoxia-inducible factors (HIFs), which regulate inflammatory signaling pathways and immune cell function, often perpetuating non-resolving inflammation seen in diseases like rheumatoid arthritis, obesity-related insulin resistance, and chronic lung diseases. Hypoxia also promotes oxidative stress and mitochondrial dysfunction, further amplifying inflammation and tissue damage.
Cancer as a Hypoxia-Adapted State
Cancer is widely recognized as a hypoxia-adapted state. In solid tumors, regions of low oxygen are not accidental but an inevitable consequence of rapid tumor growth. This hypoxic environment profoundly reshapes tumor metabolism, signaling, immune interactions, and response to therapy, making oxygen deprivation a central driver of cancer progression.
Why Tumors Become Hypoxic
Tumors become hypoxic because their growth outpaces the development of an adequate blood supply. As cancer cells proliferate, oxygen demand rises faster than new vessels can form. The vessels that do develop are typically abnormal – disorganized, fragile, and inefficient – leading to uneven perfusion and heterogeneous oxygen distribution. This produces regions of chronic hypoxia as well as cycling hypoxia, where oxygen levels fluctuate over time. At the same time, the high metabolic activity of rapidly dividing cancer cells accelerates oxygen consumption, further intensifying local oxygen stress. Together, excessive demand and dysfunctional vasculature make hypoxia a defining feature of the tumor microenvironment.
Cellular Adaptation to Hypoxia in Cancer
To survive under low-oxygen conditions, cancer cells activate coordinated adaptive programs, primarily through hypoxia-inducible factors (HIFs), especially HIF-1α. HIF signaling activates gene networks that promote metabolic reprogramming toward glycolysis, stimulate angiogenesis, enhance antioxidant defenses, and support resistance to cell death and immune surveillance. These adaptations allow tumor cells to maintain growth and survival despite oxygen deprivation.
Hypoxia-driven signaling also contributes to therapy resistance by altering DNA repair mechanisms, promoting metastasis, and fostering an immunosuppressive tumor microenvironment.
Beyond HIF: Additional Hypoxia Survival Pathways
Beyond HIF signaling, cancer cells engage additional metabolic adaptations involving glucose, glutamine, and lipid pathways, allowing survival under prolonged hypoxia and potentially contributing to therapy resistance.
Hypoxia also induces cellular stress responses, including endoplasmic reticulum stress and activation of the unfolded protein response (UPR). These pathways enhance protein quality control and stress tolerance, further supporting cancer cell survival in low-oxygen environments.
Why Hypoxia Matters in Cancer Progression
Taken together, the hypoxic tumor microenvironment drives a complex network of molecular, metabolic, and immune adaptations that define cancer as a hypoxia-adapted disease. These adaptations not only promote tumor growth and aggressiveness but also limit treatment effectiveness and contribute to disease progression, highlighting oxygen availability as a fundamental factor in cancer biology and therapy response.
Conclusion
From shaping Earth's earliest ecosystems to regulating human cells and tumor biology, oxygen has always been both constraint and catalyst. Health depends not on eliminating oxygen's risks, but on maintaining the balance that allows its regulatory power to support adaptation rather than disease. Recognizing this paradox reframes oxygen not as an enemy, but as one of biology's most powerful – and nuanced – regulators.
References
C. Balestra et al. "Oxygen Variations—Insights into Hypoxia, Hyperoxia and Hyperbaric Hyperoxia—Is the Dose the Clue?." International Journal of Molecular Sciences, 24 (2023). https://doi.org/10.3390/ijms241713472
S. Lindahl et al. "Oxygen and Life on Earth: An Anesthesiologist's Views on Oxygen Evolution, Discovery, Sensing, and Utilization." Anesthesiology, 109 (2008): 7-13. https://doi.org/10.1097/aln.0b013e31817b5a7e
D. Catling et al. "Why O2 is required by complex life on habitable planets and the concept of planetary 'oxygenation time'.." Astrobiology, 5 3 (2005): 415-38. https://doi.org/10.1089/ast.2005.5.415
K. Hocke et al. "Oxygen in the Earth System." Oxygen (2023). https://doi.org/10.3390/oxygen3030019
T. Lyons et al. "Oxygenation, Life, and the Planetary System during Earth's Middle History: An Overview." Astrobiology, 21 (2021): 906 - 923. https://doi.org/10.1089/ast.2020.2418
K. Abbas et al. "Transportation and The Use of Oxygen." International Journal of Approximate Reasoning, 1 (2020): 58-63. https://doi.org/10.20473/ijar.v1i22019.58-63
Pearl Lee et al. "Cellular adaptation to hypoxia through hypoxia inducible factors and beyond." Nature Reviews Molecular Cell Biology, 21 (2020): 268 - 283. https://doi.org/10.1038/s41580-020-0227-y
G. Semenza et al. "Oxygen sensing, homeostasis, and disease.." The New England journal of medicine, 365 6 (2011): 537-47. https://doi.org/10.1056/nejmra1011165
James W. Wilson et al. "Oxygen‐sensing mechanisms in cells." The FEBS Journal, 287 (2020). https://doi.org/10.1111/febs.15374
E. Hammarlund et al. "Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity." Science, 370 (2020). https://doi.org/10.1126/science.aba3512
R. Mallet et al. "Molecular Mechanisms of High-Altitude Acclimatization." International Journal of Molecular Sciences, 24 (2023). https://doi.org/10.3390/ijms24021698
J. Richalet et al. "Cardiovascular physiology and pathophysiology at high altitude." Nature Reviews Cardiology, 21 (2023): 75-88. https://doi.org/10.1038/s41569-023-00924-9
H. Gatterer et al. "Altitude illnesses." Nature Reviews Disease Primers, 10 (2024): 1-18. https://doi.org/10.1038/s41572-024-00526-w
Yumei Geng et al. "Reduced iron bioavailability drives acute high-altitude lung injury through HIF1α activation and mitophagy." Molecular Medicine Reports, 32 (2025). https://doi.org/10.3892/mmr.2025.13580
K. Pham et al. "Hypoxia and Inflammation: Insights From High-Altitude Physiology." Frontiers in Physiology, 12 (2021). https://doi.org/10.3389/fphys.2021.676782
Y. S. Lee et al. "Chronic tissue inflammation and metabolic disease." Genes & Development, 35 (2021): 307 - 328. https://doi.org/10.1101/gad.346312.120
T. Mcgarry et al. "Hypoxia, oxidative stress and inflammation.." Free radical biology & medicine, 125 (2018): 15-24. https://doi.org/10.1016/j.freeradbiomed.2018.03.042
E. Cummins et al. "The role of HIF in immunity and inflammation.." Molecular aspects of medicine, 47-48 (2016): 24-34. https://doi.org/10.1016/j.mam.2015.12.004
Zhou Chen et al. "Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions." Signal Transduction and Targeted Therapy, 8 (2023). https://doi.org/10.1038/s41392-023-01332-8
Chengheng Liao et al. "Tumor hypoxia: From basic knowledge to therapeutic implications." Seminars in cancer biology (2023). https://doi.org/10.1016/j.semcancer.2022.12.011
Asieh Emami Nejad et al. "The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment." Cancer Cell International, 21 (2021). https://doi.org/10.1186/s12935-020-01719-5
J. Korbecki et al. "Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms." International Journal of Molecular Sciences, 22 (2021). https://doi.org/10.3390/ijms221910701
Kritika Saxena et al. "Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression." Biomolecules, 9 (2019). https://doi.org/10.3390/biom9080339
F. Paredes et al. "Metabolic adaptation in hypoxia and cancer." Cancer letters (2021). https://doi.org/10.1016/j.canlet.2020.12.020
Wafaa Al Tameemi et al. "Hypoxia-Modified Cancer Cell Metabolism." Frontiers in Cell and Developmental Biology, 7 (2019). https://doi.org/10.3389/fcell.2019.00004
Katherine L. Eales et al. "Hypoxia and metabolic adaptation of cancer cells." Oncogenesis, 5 (2016). https://doi.org/10.1038/oncsis.2015.50
R. Shi et al. "Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications." Cells, 10 (2021). https://doi.org/10.3390/cells10030678
Shen-Han Lee et al. "HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells." Cells, 10 (2021). https://doi.org/10.3390/cells10092371
Sandhya Chipurupalli et al. "Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer." International Journal of Molecular Sciences, 20 (2019). https://doi.org/10.3390/ijms20030749
Love What You're Reading?
Add An Oasis of Healing to your Google Preferred Sources and never miss our latest articles on integrative cancer care and holistic healing.
Add to Preferred SourcesRecent Posts

The Hallmarks of Aging: What Cellular Aging Can Teach Us About Cancer

Insulin Potentiation Therapy (IPT): A Kinder, Gentler Form of Chemotherapy

4 Science-Backed Habits for a Healthier Morning Routine

What It Really Means to Get a True Second Opinion

Can Food Shape the Tumor Microenvironment





